May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Nirmit Kumar: Excellent debate on the benefit of chemo in premenopausal patients with RS ≤ 25
Mar 11, 2025, 13:39

Nirmit Kumar: Excellent debate on the benefit of chemo in premenopausal patients with RS ≤ 25

Nirmit Kumar, Senior Global Medical Strategy Leader at AstraZeneca, shared a post on X:

“Excellent debate on the benefit of chemo in premenopausal patients with Recurrence Score (RS) ≤ 25 between Sara Tolaney and Kevin Kalinsky.

Tolerability of ovarian function suppression varies so adjuvant chemotherapy usually recommended depending on patient’s clinical profile.”

Nirmit Kumar: Excellent debate on the benefit of chemo in premenopausal patients with RS ≤ 25